These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35746708)
1. SARS-CoV-2 Accessory Protein ORF8 Decreases Antibody-Dependent Cellular Cytotoxicity. Beaudoin-Bussières G; Arduini A; Bourassa C; Medjahed H; Gendron-Lepage G; Richard J; Pan Q; Wang Z; Liang C; Finzi A Viruses; 2022 Jun; 14(6):. PubMed ID: 35746708 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells. Kim IJ; Lee YH; Khalid MM; Chen IP; Zhang Y; Ott M; Verdin E J Biol Chem; 2023 Aug; 299(8):104955. PubMed ID: 37354973 [TBL] [Abstract][Full Text] [Related]
4. Glycosylated, Lipid-Binding, CDR-Like Domains of SARS-CoV-2 ORF8 Indicate Unique Sites of Immune Regulation. Wu F; Chen X; Ma Y; Wu Y; Li R; Huang Y; Zhang R; Zhou Y; Zhan J; Liu S; Xu W Microbiol Spectr; 2023 Aug; 11(4):e0123423. PubMed ID: 37318366 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions. Vinjamuri S; Li L; Bouvier M Front Immunol; 2022; 13():1035559. PubMed ID: 36353628 [TBL] [Abstract][Full Text] [Related]
6. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma. Tso FY; Lidenge SJ; Poppe LK; Peña PB; Privatt SR; Bennett SJ; Ngowi JR; Mwaiselage J; Belshan M; Siedlik JA; Raine MA; Ochoa JB; Garcia-Diaz J; Nossaman B; Buckner L; Roberts WM; Dean MJ; Ochoa AC; West JT; Wood C PLoS One; 2021; 16(3):e0247640. PubMed ID: 33661923 [TBL] [Abstract][Full Text] [Related]
7. High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19. Vietzen H; Danklmaier V; Zoufaly A; Puchhammer-Stöckl E Genet Med; 2022 Jul; 24(7):1449-1458. PubMed ID: 35488894 [TBL] [Abstract][Full Text] [Related]
8. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Flower TG; Buffalo CZ; Hooy RM; Allaire M; Ren X; Hurley JH Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33361333 [TBL] [Abstract][Full Text] [Related]
9. Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein. Hong Y; Guo H; Wei M; Zhang Y; Fang M; Cheng T; Li Z; Ge S; Yao X; Yuan Q; Xia N J Virol Methods; 2022 Sep; 307():114564. PubMed ID: 35671888 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells. Geng H; Subramanian S; Wu L; Bu HF; Wang X; Du C; De Plaen IG; Tan XD Front Immunol; 2021; 12():679482. PubMed ID: 34177923 [TBL] [Abstract][Full Text] [Related]
12. Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein. Wang X; Lam JY; Wong WM; Yuen CK; Cai JP; Au SW; Chan JF; To KKW; Kok KH; Yuen KY mBio; 2020 Oct; 11(5):. PubMed ID: 33082264 [TBL] [Abstract][Full Text] [Related]
13. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2. Zinzula L Biochem Biophys Res Commun; 2021 Jan; 538():116-124. PubMed ID: 33685621 [TBL] [Abstract][Full Text] [Related]
14. A unique view of SARS-CoV-2 through the lens of ORF8 protein. Hassan SS; Aljabali AAA; Panda PK; Ghosh S; Attrish D; Choudhury PP; Seyran M; Pizzol D; Adadi P; Abd El-Aziz TM; Soares A; Kandimalla R; Lundstrom K; Lal A; Azad GK; Uversky VN; Sherchan SP; Baetas-da-Cruz W; Uhal BD; Rezaei N; Chauhan G; Barh D; Redwan EM; Dayhoff GW; Bazan NG; Serrano-Aroca Á; El-Demerdash A; Mishra YK; Palu G; Takayama K; Brufsky AM; Tambuwala MM Comput Biol Med; 2021 Jun; 133():104380. PubMed ID: 33872970 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR. Laprise F; Arduini A; Duguay M; Pan Q; Liang C Viruses; 2024 Jun; 16(7):. PubMed ID: 39066171 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19. Arduini A; Laprise F; Liang C Viruses; 2023 Mar; 15(4):. PubMed ID: 37112851 [TBL] [Abstract][Full Text] [Related]
17. Unconventional secretion of unglycosylated ORF8 is critical for the cytokine storm during SARS-CoV-2 infection. Lin X; Fu B; Xiong Y; Xing N; Xue W; Guo D; Zaky M; Pavani K; Kunec D; Trimpert J; Wu H PLoS Pathog; 2023 Jan; 19(1):e1011128. PubMed ID: 36689483 [TBL] [Abstract][Full Text] [Related]
18. Immunoinformatic analysis of structural and epitope variations in the spike and Orf8 proteins of SARS-CoV-2/B.1.1.7. Hussain M; Shabbir S; Amanullah A; Raza F; Imdad MJ; Zahid S J Med Virol; 2021 Jul; 93(7):4461-4468. PubMed ID: 33704818 [TBL] [Abstract][Full Text] [Related]
19. Structure of SARS-CoV-2 ORF8, a rapidly evolving coronavirus protein implicated in immune evasion. Flower TG; Buffalo CZ; Hooy RM; Allaire M; Ren X; Hurley JH bioRxiv; 2020 Aug; ():. PubMed ID: 32869027 [TBL] [Abstract][Full Text] [Related]
20. Crystal Structures of Bat and Human Coronavirus ORF8 Protein Ig-Like Domain Provide Insights Into the Diversity of Immune Responses. Chen X; Zhou Z; Huang C; Zhou Z; Kang S; Huang Z; Jiang G; Hong Z; Chen Q; Yang M; He S; Liu S; Chen J; Li K; Li X; Liao J; Chen J; Chen S Front Immunol; 2021; 12():807134. PubMed ID: 34975921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]